| dbo:abstract |
Indacaterol/glycopyrronium bromide/mometasone, sold under the brand name Enerzair Breezhaler among others, is an inhalable fixed-dose combination medication for the treatment of asthma. It contains indacaterol as acetate, glycopyrronium bromide, and mometasone furoate. The most common side effects include worsening of asthma and nasopharyngitis (inflammation in the nose and throat). Other common side effects include upper respiratory tract infection (nose and throat infections) and headache. It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. An optional electronic sensor may also be co-packed with the product. The sensor will be attached to the base of the inhaler to collect data on the use of the inhaler by the patient. The sensor will send the data to an app on a smart phone or other suitable device. It was approved for medical use in the European Union in July 2020. (en) |
| dbo:alternativeName |
Enerzair Breezhaler, Zimbus Breezhaler (en) |
| dbo:casNumber |
2561489-46-9 |
| dbo:kegg |
D11861 |
| dbo:wikiPageExternalLink |
https://druginfo.nlm.nih.gov/drugportal/rn/51186-83-5 https://druginfo.nlm.nih.gov/drugportal/name/indacaterol https://druginfo.nlm.nih.gov/drugportal/name/mometasone%20furoate |
| dbo:wikiPageID |
64613381 (xsd:integer) |
| dbo:wikiPageLength |
10212 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1091908454 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbc:Novartis_brands dbr:Inhalation dbr:Corticosteroid dbr:Glycopyrronium_bromide dbr:Mometasone_furoate dbr:Anticholinergic dbr:Committee_for_Medicinal_Products_for_Human_Use dbr:Long-acting_beta-adrenoceptor_agonist dbc:Muscarinic_antagonists dbr:European_Medicines_Agency dbc:Combination_drugs dbc:Beta-adrenergic_agonists dbr:Indacaterol dbr:Muscarinic dbr:Combination_medication |
| dbp:atcPrefix |
R03 (en) |
| dbp:atcSuffix |
AL12 (en) |
| dbp:casNumber |
2561489 (xsd:integer) |
| dbp:class |
dbr:Corticosteroid dbr:Anticholinergic dbr:Muscarinic Ultra-long-acting beta-adrenoceptor agonist (en) |
| dbp:component |
Glycopyrronium bromide (en) Indacaterol (en) Mometasone furoate (en) |
| dbp:kegg |
D11861 (en) |
| dbp:legalAu |
S4 (en) |
| dbp:legalCa |
Rx-only (en) |
| dbp:legalEu |
Rx-only (en) |
| dbp:legalUk |
POM (en) |
| dbp:licenceEu |
yes (en) |
| dbp:pregnancyAu |
B3 (en) |
| dbp:routesOfAdministration |
dbr:Inhalation |
| dbp:synonyms |
QVM149 (en) |
| dbp:tradename |
Enerzair Breezhaler, Zimbus Breezhaler (en) |
| dbp:type |
combo (en) |
| dbp:wikiPageUsesTemplate |
dbt:Adrenergic_receptor_modulators dbt:Cite_web dbt:Infobox_drug dbt:Portal_bar dbt:Reflist dbt:Use_American_English dbt:Use_dmy_dates dbt:Muscarinic_acetylcholine_receptor_modulators dbt:Drugs_for_obstructive_airway_diseases |
| dcterms:subject |
dbc:Novartis_brands dbc:Muscarinic_antagonists dbc:Combination_drugs dbc:Beta-adrenergic_agonists |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:CombinationDrug dbo:Drug |
| rdfs:comment |
Indacaterol/glycopyrronium bromide/mometasone, sold under the brand name Enerzair Breezhaler among others, is an inhalable fixed-dose combination medication for the treatment of asthma. It contains indacaterol as acetate, glycopyrronium bromide, and mometasone furoate. The most common side effects include worsening of asthma and nasopharyngitis (inflammation in the nose and throat). Other common side effects include upper respiratory tract infection (nose and throat infections) and headache. (en) |
| rdfs:label |
Indacaterol/glycopyrronium bromide/mometasone (en) |
| owl:sameAs |
wikidata:Indacaterol/glycopyrronium bromide/mometasone https://global.dbpedia.org/id/DGw5o |
| prov:wasDerivedFrom |
wikipedia-en:Indacaterol/glycopyrronium_bromide/mometasone?oldid=1091908454&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:Indacaterol/glycopyrronium_bromide/mometasone |
| is dbo:wikiPageRedirects of |
dbr:Enerzair dbr:Enerzair_Breezhaler dbr:Zimbus dbr:Zimbus_Breezhaler dbr:Glycopyrronium/indacaterol/mometasone dbr:Glycopyrronium/indacaterol/mometasone_furoate dbr:Indacaterol/glycopyrronium_bromide/mometasone_furoate dbr:Indacaterol_acetate/glycopyrronium_bromide/mometasone_furoate |
| is dbo:wikiPageWikiLink of |
dbr:Enerzair dbr:Enerzair_Breezhaler dbr:ATC_code_R03 dbr:Zimbus dbr:Zimbus_Breezhaler dbr:Glycopyrronium/indacaterol/mometasone dbr:Glycopyrronium/indacaterol/mometasone_furoate dbr:Indacaterol/glycopyrronium_bromide/mometasone_furoate dbr:Indacaterol_acetate/glycopyrronium_bromide/mometasone_furoate |
| is foaf:primaryTopic of |
wikipedia-en:Indacaterol/glycopyrronium_bromide/mometasone |